| Term 
 
        | occurs in response to grief, illness, loss |  | Definition 
 
        | reactive (secondary) depression 60% |  | 
        |  | 
        
        | Term 
 
        | treatment for reactive (secondary) depression |  | Definition 
 
        | psychotherapy or acute therapeutics |  | 
        |  | 
        
        | Term 
 
        | Genetic - inability to experience ordinary pleasure, cope with daily life |  | Definition 
 
        | major (endogenous) depression 25% |  | 
        |  | 
        
        | Term 
 
        | treatment for major (endogenous) depression |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | characterized by cyclic periods of mania |  | Definition 
 
        | bipolar disorders (manic-depressive) 10-15% |  | 
        |  | 
        
        | Term 
 
        | bipolar disorders are treated with |  | Definition 
 
        | lithium in combo w/ antidepressants and/or antipsychotic agents |  | 
        |  | 
        
        | Term 
 
        | Feelings of sadness, hopelessness, despair, and inability to experience pleasure in daily activities |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | depression is due to a deficiency of NE and serotonin in key sites in the brain (monamines) |  | Definition 
 
        | biogenic amine theory for depression |  | 
        |  | 
        
        | Term 
 
        | ethusiasm, rapid though and speech, extreme self-confidence and impaired judgement |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | mania is caused by an overproduction of NE, dopamine, and serotonin |  | Definition 
 
        | biogenic amine theory for mania |  | 
        |  | 
        
        | Term 
 
        | Most common psychiatric disorder in adults |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 13-20% of the population have symptoms |  | Definition 
 
        | major depression males - 5-12% lifetime prevalence females - 9-26% lifetime prevalence |  | 
        |  | 
        
        | Term 
 
        | onset for major depression is most common in.. |  | Definition 
 
        | late 20s but this varies widely |  | 
        |  | 
        
        | Term 
 
        | comparable incidence between older adults and the general population |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | lost interest (anhedonia) sleep disturbance appetite changes depressed mood (dysthymia) concentration problems activity diminished guilt energy diminished suicidal ideation |  | 
        |  | 
        
        | Term 
 
        | Manic symptoms are thought to be due to.. |  | Definition 
 
        | neurotransmitter overactivity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inflated self esteem/grandiosity irritability pressured speech distractibility impaired judgement psychomotor agitation |  | 
        |  | 
        
        | Term 
 
        | mild to moderate depression psychotherapy is comparable to... |  | Definition 
 
        | pharmacologic intervention |  | 
        |  | 
        
        | Term 
 
        | Recommended for treatment resistant depression, vegetative depression, and psychotic depression |  | Definition 
 
        | electroconvulsive therapy |  | 
        |  | 
        
        | Term 
 
        | unlike drugs this shows a therapeutic response within 1-2 weeks |  | Definition 
 
        | electroconvulsive therapy |  | 
        |  | 
        
        | Term 
 
        | classes of drugs for treatment of depression |  | Definition 
 
        | TCA's SSRI SNRI Atypical antidepressants MAOI antimanics |  | 
        |  | 
        
        | Term 
 
        | all potentiate, either directly or indirectly, NE, 5HT |  | Definition 
 
        | classes of drugs for treatment of depression |  | 
        |  | 
        
        | Term 
 
        | Drugs used to treat depression are all... |  | Definition 
 
        | equally effective with about a 50-70% response rate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ADDIN amitriptyline desipramine doxepin imipramine nortriptyline |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Could be considered third generation TCA's |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | block the reuptake of NE and serotonin in the presynpatic neurons block alpha adrenergic, histamine & muscarinic receptors |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | elevate mood improve mental alertness increase physical activity reduce morbid preoccupation |  | 
        |  | 
        
        | Term 
 
        | therapeutic uses for TCA's |  | Definition 
 
        | moderate to severe depression some panic disorders |  | 
        |  | 
        
        | Term 
 
        | What is used to treat bed wetting (enuresis) |  | Definition 
 
        | not until the child is older than 6 imipramine (its a TCA) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pharmacokinetics of TCA's |  | Definition 
 
        | oral but inconsistent bioavailability- dosage adjustment required lipophilic -MEOS & glucuronidated in liver |  | 
        |  | 
        
        | Term 
 
        | Weight gain, antihistaminic, anticholinergic, block alpha receptors, cardiovascular |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antihistaminic effect of TCAs |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | dry mouth (xerostomia), urinary retention, constipation, blurred vision, glaucoma |  | Definition 
 
        | anticholinergic side effects of TCA |  | 
        |  | 
        
        | Term 
 
        | orthostatic hypotension, reflex tachycardia |  | Definition 
 
        | block alpha receptors side effects of TCA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | cardiovascular effects of TCA's |  | 
        |  | 
        
        | Term 
 
        | Cautions/warnings of TCA's |  | Definition 
 
        | narrow therapeutic index manic-depressive patients suicidal patients |  | 
        |  | 
        
        | Term 
 
        | 
 drug interactions of TCA's   |  | Definition 
 
        | ethanol and other CNS depressants - toxic depression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | celexa lexapro prozac, sarafem luvox paxil zoloft |  | 
        |  | 
        
        | Term 
 
        | selective inhibition of serotonin reuptake |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | fewer anticholinergic (muscarinic) effects less cardiotoxicty less weight gain no orthostatic hypotension |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | major depression OCD  bulimia/anorexia nervosa panic disorder premenstrual dysphoric disorder (PMS) postmenopausal syndrome generalized anxiety??? |  | 
        |  | 
        
        | Term 
 
        | which SSRI is used to treat OCD |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the point of slide 18?? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | pharmacokinetics of SSRI's |  | Definition 
 
        | takes 2-4 weeks to see effect slowly cleared from body steady state achieved after several weeks |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | fluoxetine has an extra half life |  | Definition 
 
        | 50 hours because of norfluoxetine active metabolite (t1/2 =10 days) |  | 
        |  | 
        
        | Term 
 
        | drug interactions of SSRI's |  | Definition 
 
        | potent inhibitors of P 450 (CYP2D6)  7% caucasian population lack this isoenzyme |  | 
        |  | 
        
        | Term 
 
        | nausea sleep disturbances sexual dysfunction GI, anorexia weight loss children/teenagers --> suicidal ideation hallucinations |  | Definition 
 
        | adverse reactions of SSRI's |  | 
        |  | 
        
        | Term 
 
        | Sexual dysfunction associated with SSRI's |  | Definition 
 
        | loss of libido delayed ejaculation anorgasmia incidence is 30-50% more common males |  | 
        |  | 
        
        | Term 
 
        | If a depressed person cannot sleep you should give them.. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | if a depressed person has insomnia you should give them |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Safer than TCA's in overdoses unique mechanism of action, used when SSRI's have failed not as activating as fluoxetine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Depression associated w/ neuropathic pain (backache & muscle ache) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Unlike TCA's  no adrenergic, muscarinic, histaminergic receptor blockade fewer adverse effects |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nausea, headache, dry mouth, somnolence, sexual dysfunction |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | buproprion (wellbutrin) mirtazapine (Remeron) trazodone nefazodone |  | 
        |  | 
        
        | Term 
 
        | Weak NE/DA reuptake inhibitor no anticholinergic/antihistamine/alpha blockade |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ has a low incidence of sexual dysfunction therfore alternative for SSRI's |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | has been used in "SR" form for smoking cessation |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | xerostomia, sweating, nervousness, tremor, lowers seizure threshold |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | alpha 2 antagonist serotonin receptor antagonist increases 5HT and NE neurotransmission |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | increased appetite, weight gain no anticholinergic little sexual dysfunction minimal drug-drug interactions |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5HT2A antagonists weak 5HT reuptake inhibitors |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | desensitizes 5HT1A presynaptic receptors = |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | low incidence of sexual dysfunction but with trazadone may see.. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | fewer anticholinergic side effects than TCA's |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | hepatotoxicity pulled in Canada and USA  only generics remain available |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | only inhibits MAO- B so only for dopamine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | inhibit monoamine oxidase increase stores of intraneuronal NE, dopamine, & serotonin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | food-drug interactions are seen with? |  | Definition 
 
        | MAOI inhibition of MAO in the GI tract = increased tyramine |  | 
        |  | 
        
        | Term 
 
        | Tyramine will release stored EPI/NE causing... |  | Definition 
 
        | hypertension tachycardia nausea arrhythmias stroke hypertensive crisis induced by MAOI's med emergency |  | 
        |  | 
        
        | Term 
 
        | only used today in patients refractory or hypersensitive to other antidepressants strong anxiety, phobic states |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | labile mood rejection sensitivity appetite disorders |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | drowsiness, orthostatic hypotension, blurred vision, xerostomia, constipation/urinary retention |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | adverse effects of tyramine |  | Definition 
 
        | headache, hypertension, stroke |  | 
        |  | 
        
        | Term 
 
        | dietary restriction of MAOI |  | Definition 
 
        | avoid use w/ aged cheeses, wine, beer, organ meats, sausage, seafood, avocados this limits therapy |  | 
        |  | 
        
        | Term 
 
        | the full effects of these drugs is delayed several weeks |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | the effects are also continued several weeks after discontued need to wait @ least 2 weeks after d/c to start new drug |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Do not use with SSRI's (wait 6 weeks) could cause serotonin syndrome |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | potentially fatal interaction cause by the combination of 2 or more drugs that enhance serotonin transmission |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | anxiety, shivering, tremor, diaphoresis death has been attributed to malignant hyperthermia |  | Definition 
 
        | serotonin syndrome symptoms |  | 
        |  | 
        
        | Term 
 
        | If someone has a mild case of serotonin syndrome then you should...... |  | Definition 
 
        | discontinue serotonergic antagonists and symptoms should resolve in 1-2 days |  | 
        |  | 
        
        | Term 
 
        | If someone is having a severe serotonin syndrome reaction then.... |  | Definition 
 
        | serotonergic antagonists such as methysergide and propranolol have been used |  | 
        |  | 
        
        | Term 
 
        | most cases of serotonin syndrome are due to.. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | other problem combinations that cause serotonin syndrome include |  | Definition 
 
        | meperidine, TCA, dextromethorphan, lithium, triptans, and St. John's wort |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | drug selection in depression is based on |  | Definition 
 
        | patient history safety in overdose adverse effects patients age ease of admin possible interactions |  | 
        |  | 
        
        | Term 
 
        | drug specific  adverse effects to consider when selecting a drug for depression |  | Definition 
 
        | TCA's are more sedating than SSRI TCA's cause more anti-cholinergic side effects |  | 
        |  | 
        
        | Term 
 
        | patient specific things to consider when considering drug selection in depression |  | Definition 
 
        | TCA's can cause weight gain so avoid in obese pt's wellbutrin will lower seizure threshold so avoid in epilepsy best not to use antidepressants during pregnancy |  | 
        |  | 
        
        | Term 
 
        | considered the most deadly psychiatric illness due to the suicide rate in patients 10-15% suicide rate if left untreated |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Both characterized by a distinct period of abnormally and persistently elevated, expansive, or irritable mood |  | Definition 
 
        | manic and hypomanic epidodes |  | 
        |  | 
        
        | Term 
 
        | ethusiasm, rapid thought and speech, extreme self confidence |  | Definition 
 
        | manic and hypomanic episodes |  | 
        |  | 
        
        | Term 
 
        | the difference between manic and hypomanic is that manic episodes are... |  | Definition 
 
        | severe enough to impair functioning (self-care, work, or social functioning) |  | 
        |  | 
        
        | Term 
 
        | used in the treatment of manic-depressive illnesses standard of therapy for decades (60-80% effective) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | preventitive for manic/depressive symptoms not used for acute mania as delayed drug effect |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MOA : unknown, may work by altering the cellular concentration of inositol triphosphate  (2nd messenger) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | may be necessary to use benzodiazepines (clonazepam) or antipsychotics until onset |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lithium salts are a toxic drug with.. |  | Definition 
 
        | a narrow therapeutic index requires monitoring |  | 
        |  | 
        
        | Term 
 
        | This drug is a potential teratogen |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse effects - tremors, weight gain, confusion, convulsions |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Many _______ will increase lithium due to an enhanced reabsorption of sodium and lithium secondary to inhibition of prostaglandin therapy |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | New treatment for bipolar disorder |  | Definition 
 
        | pyrexia + prozac atypical antipsychotic + SSRI antidepressant combo of pyrexia + prozac = symbyax Anticonvulsants : mood stabilizers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | carbamazepine (tegretol) valproic acid (Depakote) Lamictal |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |